Akèy › Sklerodèm › Arizona › Tucson
Etid klinik pou Sklerodèm nan Tucson, AZ
3 etid pou Sklerodèm ap chèche patisipan nan sit nan ak bò kote Tucson (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Ap rekriteFaz 2/3
- GSK Investigational Site, Tucson
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Ap rekriteFaz 2
- Artiva Investigational Site Tucson, Tucson
A Study of AZD0120 in Autoimmune Diseases
Ap rekriteFaz 1
- Research Site, Tucson
Etid Sklerodèm nan lòt vil
- New York City, NY11 etid
- Chicago, IL10 etid
- Ann Arbor, MI10 etid
- Houston, TX9 etid
- Durham, NC7 etid
- Los Angeles, CA7 etid
- Boston, MA7 etid
- Baltimore, MD6 etid
- New Orleans, LA6 etid
- Philadelphia, PA6 etid
- Pittsburgh, PA5 etid
- Dallas, TX5 etid
Lòt etid nan Tucson
- Kansè nan tete20 etid
- Obèsite17 etid
- Kansè Poumon ki pa ti selil17 etid
- Sipwa15 etid
- Kansè Metastatik14 etid
- Maladi kadyovaskilè12 etid
- Kansè (tout kalite)12 etid
- Kansè pwostat11 etid
- Kansè kolorektal11 etid
- Maladi fwa steatotik10 etid
- Dyabèt Tip 210 etid
- Hypertension artérielle10 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.